Evaluation of Near-Patient B-Type Natriuretic Peptide Assay in Predicting Patent Ductus Arteriosus Closure in Preterm Infants (≤27+6 Weeks) with Low Dose Indometacin Prophylaxis Regime
2011
Evaluation of Near-Patient B-Type Natriuretic Peptide Assay in Predicting Patent Ductus Arteriosus Closure in Preterm Infants (≤27+6 Weeks) with Low Dose Indometacin Prophylaxis Regime
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI